NRIX
Nurix Therapeutics, Inc. Common stock#82 · 2024HTFCYearly return
+84%
Peak return
+189%
Max drawdown
-38%
ADR (20 days)
+5.9%
Base
23 days / -23.9%
Prior run
+176%
Breakout volume
2.0x
Pivot
$15.65
Catalyst Earnings/Guidance2024-04-10Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate UpdateGlobeNewswire Inc.
Earnings, Guidance oder Umsatz-/EPS-Revision als Neubewertungsanker.
Healthcare · Healthcare & Biotech
Continue in the full Atlas
Drawing, alerts, replay and the live scanner built on the same criteria are part of WickedDesk. Compare NRIX with the current market directly.